CN103432530B - 一种治疗子宫内膜异位症的中药组合物及其制备方法 - Google Patents
一种治疗子宫内膜异位症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103432530B CN103432530B CN201310401962.3A CN201310401962A CN103432530B CN 103432530 B CN103432530 B CN 103432530B CN 201310401962 A CN201310401962 A CN 201310401962A CN 103432530 B CN103432530 B CN 103432530B
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- radix
- herba
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 123
- 201000009273 Endometriosis Diseases 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 41
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 241000218176 Corydalis Species 0.000 claims abstract description 15
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 12
- 241001057584 Myrrha Species 0.000 claims abstract description 11
- 238000011282 treatment Methods 0.000 claims description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 16
- 239000000341 volatile oil Substances 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 11
- 241001250596 Pleione Species 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- -1 soak 0.5-1.5 hour Substances 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000000703 high-speed centrifugation Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 196
- 210000004369 blood Anatomy 0.000 abstract description 192
- 208000002193 Pain Diseases 0.000 abstract description 106
- 230000036407 pain Effects 0.000 abstract description 104
- 230000000694 effects Effects 0.000 abstract description 32
- 210000003734 kidney Anatomy 0.000 abstract description 23
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 230000003213 activating effect Effects 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 description 38
- 210000001015 abdomen Anatomy 0.000 description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 34
- 230000017531 blood circulation Effects 0.000 description 27
- 208000005171 Dysmenorrhea Diseases 0.000 description 26
- 206010013935 Dysmenorrhoea Diseases 0.000 description 26
- 210000004291 uterus Anatomy 0.000 description 26
- 201000010099 disease Diseases 0.000 description 24
- 208000024891 symptom Diseases 0.000 description 24
- 206010007247 Carbuncle Diseases 0.000 description 23
- 230000007812 deficiency Effects 0.000 description 22
- 208000014674 injury Diseases 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 21
- 239000003826 tablet Substances 0.000 description 21
- 208000004998 Abdominal Pain Diseases 0.000 description 20
- 230000001717 pathogenic effect Effects 0.000 description 20
- 208000001848 dysentery Diseases 0.000 description 19
- 201000000736 Amenorrhea Diseases 0.000 description 18
- 206010001928 Amenorrhoea Diseases 0.000 description 18
- 208000019255 Menstrual disease Diseases 0.000 description 18
- 231100000540 amenorrhea Toxicity 0.000 description 18
- 230000004087 circulation Effects 0.000 description 18
- 208000006820 Arthralgia Diseases 0.000 description 17
- 201000007227 lymph node tuberculosis Diseases 0.000 description 17
- 230000008961 swelling Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 244000052769 pathogen Species 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 15
- 206010000087 Abdominal pain upper Diseases 0.000 description 14
- 230000008736 traumatic injury Effects 0.000 description 14
- 210000002216 heart Anatomy 0.000 description 13
- 239000002398 materia medica Substances 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 208000011580 syndromic disease Diseases 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 12
- 230000000202 analgesic effect Effects 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 238000002560 therapeutic procedure Methods 0.000 description 12
- 206010027514 Metrorrhagia Diseases 0.000 description 11
- 241000411851 herbal medicine Species 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 210000004914 menses Anatomy 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 9
- 210000000481 breast Anatomy 0.000 description 9
- 208000035475 disorder Diseases 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 239000006187 pill Substances 0.000 description 9
- 239000002574 poison Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 206010012335 Dependence Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 206010019909 Hernia Diseases 0.000 description 8
- 208000019790 abdominal distention Diseases 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 208000001780 epistaxis Diseases 0.000 description 8
- 239000000686 essence Substances 0.000 description 8
- 208000021267 infertility disease Diseases 0.000 description 8
- 230000002175 menstrual effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 206010040943 Skin Ulcer Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 210000001624 hip Anatomy 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 231100000019 skin ulcer Toxicity 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000002980 postoperative effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 5
- 208000032170 Congenital Abnormalities Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 230000002357 endometrial effect Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000000629 knee joint Anatomy 0.000 description 5
- 208000004396 mastitis Diseases 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 201000008827 tuberculosis Diseases 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 4
- 206010008631 Cholera Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010018498 Goitre Diseases 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000007106 menorrhagia Diseases 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 238000004080 punching Methods 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000001850 reproductive effect Effects 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 3
- 208000007415 Anhedonia Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- 206010011732 Cyst Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- 241000612118 Samolus valerandi Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000024780 Urticaria Diseases 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 208000024756 faint Diseases 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 208000003512 furunculosis Diseases 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000002357 laparoscopic surgery Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- RFKQJTRWODZPHF-UHFFFAOYSA-N Dehydrocorydaline Chemical compound COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C(C)=C3C2=C1 RFKQJTRWODZPHF-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 2
- 241001489978 Eupolyphaga Species 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000201281 Limonium gmelinii Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 235000019082 Osmanthus Nutrition 0.000 description 2
- 241000333181 Osmanthus Species 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010034238 Pelvic adhesions Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000195474 Sargassum Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000007698 birth defect Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000027326 copulation Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 229960000766 danazol Drugs 0.000 description 2
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 206010019847 hepatosplenomegaly Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000018893 Cercis canadensis var canadensis Nutrition 0.000 description 1
- 240000000024 Cercis siliquastrum Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010053398 Clonic convulsion Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- BJJXHLWLUDYTGC-ANULTFPQSA-N Gestrinone Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](CC)([C@](CC3)(O)C#C)C=C3)C3=C21 BJJXHLWLUDYTGC-ANULTFPQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 241000201282 Limonium Species 0.000 description 1
- 241001149107 Limonium bicolor Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000124449 Paeonia obovata Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000594384 Potentilla conferta Species 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010074268 Reproductive toxicity Diseases 0.000 description 1
- 206010065951 Retrograde menstruation Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 240000001636 Trillium erectum Species 0.000 description 1
- 235000008325 Trillium erectum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000016599 Uterine disease Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 210000003717 douglas' pouch Anatomy 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 229940046085 endocrine therapy drug gonadotropin releasing hormone analogues Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Natural products CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 229960004761 gestrinone Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical class C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 206010028320 muscle necrosis Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 231100000372 reproductive toxicity Toxicity 0.000 description 1
- 230000007696 reproductive toxicity Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000005181 root of the tongue Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
试验组 | 受孕率 | 活胎数 | 死胎数 | 活胎质量 |
第一组 | 99.9% | 49 | 2 | 良好 |
第二组 | 99.3% | 48 | 1 | 良好 |
第三组 | 98.9% | 49 | 1 | 良好 |
第四组 | 99.1% | 48 | 2 | 良好 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310401962.3A CN103432530B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗子宫内膜异位症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310401962.3A CN103432530B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗子宫内膜异位症的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103432530A CN103432530A (zh) | 2013-12-11 |
CN103432530B true CN103432530B (zh) | 2014-12-17 |
Family
ID=49686314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310401962.3A Active CN103432530B (zh) | 2013-09-06 | 2013-09-06 | 一种治疗子宫内膜异位症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432530B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103990066A (zh) * | 2014-05-19 | 2014-08-20 | 陈筠 | 一种治疗子宫内膜异位症的中药组合物 |
CN105287930A (zh) * | 2015-11-30 | 2016-02-03 | 丁孝娥 | 一种治疗子宫内膜异位症的中药组合物及其制备方法 |
IT201600080802A1 (it) * | 2016-08-01 | 2018-02-01 | Gionas S R L | Medicamento per il trattamento e/o la prevenzione dell’endometriosi. |
CN106110206B (zh) * | 2016-08-04 | 2021-03-09 | 贵阳中医学院 | 一种治疗子宫内膜异位症的中药制剂及其制备方法 |
CN109078143B (zh) * | 2018-10-25 | 2020-12-15 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗子宫内膜异位症的中药组合物及其应用 |
CN115624605B (zh) * | 2022-10-28 | 2023-09-26 | 中国人民解放军海军军医大学第一附属医院 | 一种治疗卵巢型子宫内膜异位症的中药组合物 |
CN117205231B (zh) * | 2023-11-08 | 2024-02-02 | 云南中医药大学 | 一种养血增膜的中药组合物及其制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102114140A (zh) * | 2010-05-18 | 2011-07-06 | 胡佳顶 | 一种治疗子宫内膜异位症的中药口服汤剂 |
CN102716417A (zh) * | 2012-06-15 | 2012-10-10 | 祁连明 | 一种治疗妇科病的中药制剂及其制备方法 |
CN102836387A (zh) * | 2011-06-23 | 2012-12-26 | 王东 | 一种治疗子宫内膜异位症的中药方 |
-
2013
- 2013-09-06 CN CN201310401962.3A patent/CN103432530B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102114140A (zh) * | 2010-05-18 | 2011-07-06 | 胡佳顶 | 一种治疗子宫内膜异位症的中药口服汤剂 |
CN102836387A (zh) * | 2011-06-23 | 2012-12-26 | 王东 | 一种治疗子宫内膜异位症的中药方 |
CN102716417A (zh) * | 2012-06-15 | 2012-10-10 | 祁连明 | 一种治疗妇科病的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103432530A (zh) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432530B (zh) | 一种治疗子宫内膜异位症的中药组合物及其制备方法 | |
CN102784363B (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
CN103520654A (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN103751716B (zh) | 一种治疗肾结石和胆结石的药物组合物 | |
CN101095923B (zh) | 一种治疗宫外孕的中药 | |
CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
CN105194542A (zh) | 跌打中药酒 | |
CN104491831A (zh) | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN105250619A (zh) | 一种治疗内在性子宫内膜异位症的中药及其制备方法 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
CN104324330A (zh) | 一种治疗淤血蓄结型子宫肌瘤的中药组合物及其制备方法 | |
CN104873948A (zh) | 一种治疗血管穿刺引起动脉血栓的中药制剂及其制备方法 | |
CN107213360A (zh) | 一种治疗重型肌无力的中药组合物 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN106266109A (zh) | 一种治疗泌尿系统结石的中药组合物及其制备方法 | |
CN105816672A (zh) | 用于泌尿系超声碎石后辅助排出的中药冲剂及制备方法 | |
CN104771637A (zh) | 治疗胆结石的利胆排石剂及制备方法 | |
CN105106696A (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN104721753A (zh) | 一种治疗肝风内动型脑瘤的药物及制备方法 | |
CN104257871B (zh) | 用于治疗湿热毒蕴型急性网状淋巴管炎的药物组合物及其制备方法 | |
CN103520643A (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN104645222A (zh) | 治疗妇女产后高热不退的中药剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YUNNAN PANLONGYUNHAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIANG YIPENG Effective date: 20141119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Jialiang Inventor after: Zeng Lipin Inventor after: Du Bo Inventor before: Liang Yipi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 675000 CHUXIONG YI AUTONOMOUS PREFECTURE, YUNNAN PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIANG YIPENG TO: JIAO JIALIANG CENG LIPIN DU BO |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141119 Address after: 675000 Yunnan city of Chuxiong Province Economic and Technological Development Zone Avenue Zixi Applicant after: Yunnan Panlong Yunhai Pharmaceutical Co., Ltd. Address before: 250000 Shandong City, Ji'nan, No. ten via road 4, building 4, unit 25156, 402 Applicant before: Liang Yipi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |